Newsletter | November 18, 2020

11.18.20 -- Research: 5 Challenges In Finding Rare Disease Patients

Featured Articles
Top 5 Challenges In Finding Rare Disease Patients

ISR asked respondents with involvement in patient recruitment and retention activities for Phase 2/3 rare disease studies about their pain points regarding patient recruitment.

The Making Of A Pharma CEO

The story of how Paula Ragan, Ph.D., went from aspiring academic to biopharmaceutical protégé to CEO of X4 Pharmaceuticals, a six-year-old company focused on improving the immune system for treating rare diseases.

What — If Any — “Silver Linings” Have You Observed Taking Place At Your Company Resulting From The Chaos Caused By COVID-19?

See the answer from Tom DiLenge, president, advocacy, law and public policy division for the Biotechnology Innovation Organization (BIO).

Web-Exclusive Content
Charting A Course Into The Unknown: Manufacturer Considerations In Gene Therapy

As manufacturers and other healthcare stakeholders try and chart a course in the emerging gene therapy field, there are many considerations manufacturers should be mindful of as they plan for a future launch into this emerging space.

Accelerating Your Biopharma Startup’s Path To The Clinic

Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, and Dara Lockert, founder and executive director of Spannerwerks, a consultancy, share best practices and lessons learned during the drive to get a biopharma startup to the clinic as quickly as possible. 

November 2020 Digital Edition

Inside you will find more on:

  • Pharma Patents
  • Fundraising Trends
  • Leadership Lessons
  • Companies To Watch

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.